person

Cecilia K.

Country
Sweden
Department
ME Hematologi

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
48
Sites with multiple studies

Has run more than one trial at 48 of 114 partner sites.

Specializations

Hematologic Disorders

The investigator specializes in studying and treating systemic mastocytosis, with particular emphasis on its indolent forms. Their research encompasses the evaluation of novel therapeutic approaches for patients with indolent systemic mastocytosis (ISM) and smoldering systemic mastocytosis (SSM).

  • Mast Cell Disorders
  • Rare Hematologic Conditions
  • Systemic Disease Management

Their clinical focus includes investigating targeted therapies that address the underlying mechanisms of mast cell disorders.

Therapeutic Development

The investigator is involved in advancing treatment options for rare hematologic disorders, with expertise in evaluating novel therapeutic compounds. Their work includes studying innovative treatment approaches for patients with mast cell-related conditions.

  • Novel Drug Development
  • Treatment Optimization
  • Clinical Efficacy Assessment

Their research aims to establish effective dosing strategies for emerging therapies in mastocytosis treatment.

Patient Care Innovation

The investigator focuses on developing treatment strategies for patients with rare systemic diseases. Their expertise extends to managing complex manifestations of systemic mastocytosis and related conditions.

  • Disease Management Strategies
  • Symptom Control
  • Quality of Life Improvement

Their work emphasizes improving therapeutic outcomes for patients with indolent forms of mastocytosis.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.